Matrix metalloproteinase 2 overexpression and prognosis in colorectal cancer: a meta-analysis
Autor: | Hongguo Gao, Bo Yu, Jingwen Mu, Changwei Ji, Mumu Shi |
---|---|
Rok vydání: | 2012 |
Předmět: |
Male
Oncology medicine.medical_specialty Colorectal cancer Gene Expression Matrix metalloproteinase Bioinformatics Internal medicine Odds Ratio Genetics medicine Humans In patient Molecular Biology business.industry Hazard ratio General Medicine Odds ratio Publication bias Prognosis medicine.disease Confidence interval Meta-analysis Matrix Metalloproteinase 2 Female Colorectal Neoplasms business Publication Bias |
Zdroj: | Molecular Biology Reports. 40:617-623 |
ISSN: | 1573-4978 0301-4851 |
DOI: | 10.1007/s11033-012-2100-3 |
Popis: | Many studies investigated the relationship between matrix metalloproteinase 2 (MMP-2) overexpression and survival in patients with colorectal cancer (CRC), but yielded inconsistent results. To derive a more precise estimate of the prognostic significance of MMP-2 overexpression, we reviewed published studies and carried out a meta-analysis. Eligible articles were identified for the period up to March 2012 in electronic databases. To evaluate the correlation between MMP-2 overexpression and the prognosis in CRC, pooled hazard ratio (HR) and its 95 % confidence interval (95 % CI) for poorer overall and progression-free survival were appropriately derived from fixed-effects or random-effects models using standard meta-analysis techniques. Thirteen studies with a total of 1,919 CRC patients stratifying overall survival (OS) and/or progression-free survival in CRC patients by MMP-2 expression status were eligible for analysis. Ten studies investigated the OS in a total of 1,612 cases with CRC, and five studies investigated the progression-free survival in a total of 508 patients CRC. The combined HR estimate for OS and progression-free survival was 1.74 (95 % CI, 1.34-2.26) and 1.35 (95 % CI, 1.07-1.80), respectively. Both subgroup analyses and sensitivity analysis further identified the prognostic role of MMP-2 overexpression in patients with CRC. There was no evidence for publication bias. In conclusion, MMP-2 overexpression is associated with poorer overall and progression-free survival in patients with CRC. |
Databáze: | OpenAIRE |
Externí odkaz: |